By Gary Thomas
TriMarkPublications.com, publisher of market research reports of life sciences, healthcare and biotechnology domains, has published its latest report on the Global Flow Cytometry market. The report states that the global market for flow cytometry is set to scale up to $4.9 billion by 2017.
The three main categories of applications for flow cytometry are pharmaceuticals, clinical diagnostic and laboratory research. The study therefore covers the related attractive growth areas such as Stem Cell Research, Multiplex Bead Assays, Minimum Residual Disease (MRD), CD4 T-Cell Testing, Immunophenotyping of Leukemias and Lymphomas, Paroxysmal Nocturnal Hemoblobinuria and Platelet Associated Immunoglobulin Assays.
The report provides sales forecast and market share details of leading suppliers and manufacturers of flow cytometry equipment worldwide. The companies under focus include Beckman Coulter, BD Bioscience, Apogee flow, Cell Signaling, Promega, Sigma-Aldrich, MiraiBio, EMD Millipore, CytonomeST, Takara, Verity Software House, TTP LabTech, Miltenyi, Life Technologies, ALPCO, U.S. Biological, Nihon Kohden, AbD Serotec, Bay, BioCytex, Cira Discovery, Luminex, IntelliCyt, Stratedigm, Techne, Union Biometrica, Soft Flow and DVS. Of these companies, Beckman Coulter and BD Biosciences account for 49% of the market. Though 86% of the global flow cytometry market is held by Japan, Europe and the US, the BRIC (Brazil, Russia, India and China) nations are gaining on the leaders with a rapid cumulative annual growth rate (CAGR) of 20%.